...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

Thx Tada!  That I didn't know nor I'm assuming do many others on this board either.  

At this point, I'm happy to wait out another two weeks and see what comes from the FDA.  

Appreciate your G2!

10BagR

 

Share
New Message
Please login to post a reply